Zaragozic acid A

Zaragozic acid A is a lipid of Polyketides (PK) class. Zaragozic acid a is associated with abnormalities such as Hypercholesterolemia, Diabetes Mellitus, Non-Insulin-Dependent, Cardiovascular morbidity, Atherosclerosis and Infection. The involved functions are known as Anabolism, Sterol Biosynthesis Pathway, isoprenoid biosynthetic process, Biochemical Pathway and Adverse effects. Zaragozic acid a often locates in Endoplasmic reticulum, membrane, viral nucleocapsid location, Cell surface, Hepatic and Membrane. The associated genes with Zaragozic acid A are DPM1 gene, PMM2 gene, STN gene, SLC6A7 gene and Amyloid beta-Protein Precursor. The related lipids are Sterols, Fatty Acids, Membrane Lipids, farnesoic acid and Unilamellar Vesicles. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Zaragozic acid A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Zaragozic acid A?

Zaragozic acid A is suspected in Hypercholesterolemia, Cardiovascular Diseases, Prion Diseases, Coronary Artery Disease, Diabetes Mellitus, Non-Insulin-Dependent, Cardiovascular morbidity and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Zaragozic acid A

MeSH term MeSH ID Detail
Leukemia, Myeloid D007951 52 associated lipids
Biliary Fistula D001658 13 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with Zaragozic acid A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Zaragozic acid A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Zaragozic acid A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Zaragozic acid A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Zaragozic acid A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Zaragozic acid A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Zaragozic acid A?

Mouse Model

Mouse Model are used in the study 'Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid.' (Haeuptle MA et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Zaragozic acid A

Download all related citations
Per page 10 20 50 100 | Total 105
Authors Title Published Journal PubMed Link
McHale-Owen H and Bate C Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers. 2018 Biochim. Biophys. Acta pmid:29247837
Liu N et al. Identification and Heterologous Production of a Benzoyl-Primed Tricarboxylic Acid Polyketide Intermediate from the Zaragozic Acid A Biosynthetic Pathway. 2017 Org. Lett. pmid:28605916
Liddle E et al. In vitro kinetic study of the squalestatin tetraketide synthase dehydratase reveals the stereochemical course of a fungal highly reducing polyketide synthase. 2017 Chem. Commun. (Camb.) pmid:28106181
Lanterna C et al. The administration of drugs inhibiting cholesterol/oxysterol synthesis is safe and increases the efficacy of immunotherapeutic regimens in tumor-bearing mice. 2016 Cancer Immunol. Immunother. pmid:27520505
Bonsch B et al. Identification of genes encoding squalestatin S1 biosynthesis and in vitro production of new squalestatin analogues. 2016 Chem. Commun. (Camb.) pmid:27056201
Pastar I et al. Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration. 2016 J. Cell. Physiol. pmid:26916741
Rondini EA et al. Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes. 2016 J. Pharmacol. Exp. Ther. pmid:27225895
Pant A and Kocarek TA Role of Phosphatidic Acid Phosphatase Domain Containing 2 in Squalestatin 1-Mediated Activation of the Constitutive Androstane Receptor in Primary Cultured Rat Hepatocytes. 2016 Drug Metab. Dispos. pmid:26700959
Rondini EA et al. Transcriptional Regulation of Cytosolic Sulfotransferase 1C2 by Intermediates of the Cholesterol Biosynthetic Pathway in Primary Cultured Rat Hepatocytes. 2015 J. Pharmacol. Exp. Ther. pmid:26427720
da Silva MF et al. In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway. 2015 Antimicrob. Agents Chemother. pmid:26055383
Zúñiga-Hertz JP et al. Distinct pathways of cholesterol biosynthesis impact on insulin secretion. 2015 J. Endocrinol. pmid:25453115
Bentinger M et al. Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis. 2014 Biochim. Biophys. Acta pmid:24747199
Hamid PH et al. Differential inhibition of host cell cholesterol de novo biosynthesis and processing abrogates Eimeria bovis intracellular development. 2014 Parasitol. Res. pmid:25199551
Quade-Lyssy P et al. Statins stimulate the production of a soluble form of the receptor for advanced glycation end products. 2013 J. Lipid Res. pmid:23966666
Liu CI et al. Binding modes of zaragozic acid A to human squalene synthase and staphylococcal dehydrosqualene synthase. 2012 J. Biol. Chem. pmid:22474324
Cannell RJ et al. Follow-up of natural products isolation. 2012 Methods Mol. Biol. pmid:22367909
Fünfschilling U et al. Critical time window of neuronal cholesterol synthesis during neurite outgrowth. 2012 J. Neurosci. pmid:22649242
Stein W et al. Prevention of transplant coronary artery disease by prenylation inhibitors. 2011 J. Heart Lung Transplant. pmid:21458297
Henneman L et al. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS. 2011 Biochim. Biophys. Acta pmid:21237288
Haeuptle MA et al. Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid. 2011 J. Biol. Chem. pmid:21183681
Weivoda MM and Hohl RJ Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation. 2011 Endocrinology pmid:21586555
Wang Y and Metz P A general access to zaragozic acids: total synthesis and structure elucidation of zaragozic acid D and formal syntheses of zaragozic acids A and C. 2011 Chemistry pmid:21328504
Vukelic S et al. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor. 2010 J. Biol. Chem. pmid:19903814
Kojro E et al. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis. 2010 J. Alzheimers Dis. pmid:20413873
Kahlon AK et al. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus. 2010 J. Biomol. Struct. Dyn. pmid:20645653
Linetti A et al. Cholesterol reduction impairs exocytosis of synaptic vesicles. 2010 J. Cell. Sci. pmid:20103534
Forsman U et al. 4-Nitrobenzoate inhibits coenzyme Q biosynthesis in mammalian cell cultures. 2010 Nat. Chem. Biol. pmid:20526342
Paintlia AS et al. Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells. 2010 Glia pmid:20578043
Rothwell C et al. Cholesterol biosynthesis modulation regulates dengue viral replication. 2009 Virology pmid:19419745
Bedi M et al. Inhibition of squalene synthase upregulates PCSK9 expression in rat liver. 2008 Arch. Biochem. Biophys. pmid:18054775
Lasserre R et al. Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. 2008 Nat. Chem. Biol. pmid:18641634
Daicho K et al. The ergosterol biosynthesis inhibitor zaragozic acid promotes vacuolar degradation of the tryptophan permease Tat2p in yeast. 2007 Biochim. Biophys. Acta pmid:17531951
Brusselmans K et al. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation. 2007 J. Biol. Chem. pmid:17483544
Wilson R et al. Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide. 2007 BMC Neurosci pmid:18034899
Molina S et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. 2007 J. Hepatol. pmid:17156886
Schneiders MS et al. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency. 2006 Arthritis Rheum. pmid:16802371
Hirata Y et al. Total syntheses of zaragozic acids A and C by a carbonyl ylide cycloaddition strategy. 2006 Chemistry pmid:17106907
Handschin C et al. Species-specific mechanisms for cholesterol 7alpha-hydroxylase (CYP7A1) regulation by drugs and bile acids. 2005 Arch. Biochem. Biophys. pmid:15629111
Tong H et al. Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. 2005 Anal. Biochem. pmid:15582558
Flury I et al. INSIG: a broadly conserved transmembrane chaperone for sterol-sensing domain proteins. 2005 EMBO J. pmid:16270032
Loike JD et al. Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:15345508
Bate C et al. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. 2004 J. Biol. Chem. pmid:14754889
Cox RJ et al. Rapid cloning and expression of a fungal polyketide synthase gene involved in squalestatin biosynthesis. 2004 Chem. Commun. (Camb.) pmid:15489970
Li HY et al. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. 2003 Blood pmid:12506040
Pedretti A et al. Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking. 2002 J. Med. Chem. pmid:11906287
Ourlin JC et al. A Link between cholesterol levels and phenobarbital induction of cytochromes P450. 2002 Biochem. Biophys. Res. Commun. pmid:11846416
Calter MA and Zhu C Scope and diastereoselectivity of the "interrupted" Feist-Bénary reaction. 2002 Org. Lett. pmid:11796051
Calter MA et al. Rapid synthesis of the 7-deoxy zaragozic acid core. 2002 Org. Lett. pmid:11796052
Pandak WM et al. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. 2002 Hepatology pmid:12029625
Naito S et al. Novel approach to the zaragozic acids. Enantioselective total synthesis of 6,7-dideoxysqualestatin H5. 2002 J. Org. Chem. pmid:12054955